BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Boehringer and Lilly’s Jardiance Hits Mark in Decreasing Risk of Death in Heart Failure

  Boehringer Ingelheim and Eli Lilly and Company announced that the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes, met the primary endpoint.

  July 30, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Genentech Cuts 474 Jobs in Move Not Related to COVID-19 Programs

  Genentech is eliminating 474 employees, mostly based out of its South San Francisco facilities. The job cuts are expected to be permanent.

  July 30, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Bio NC

  Research Roundup: Can Flu and Pneumonia Vaccines Prevent Alzheimer’s and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  July 30, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Policy

  FDA Issues Template for At-Home COVID-19 Testing

  The U.S. FDA issued a new template for clinical test developers that is designed to assist these companies in developing and submitting emergency use authorization (EUA) for COVID-19 tests that can be performed at home or in other settings besides laboratories.

  July 30, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Scientists Take Do-It-Yourself, Untested COVID-19 Vaccine

  The vaccine was developed by Preston Estep, a former graduate student of Harvard University geneticist George Church.

  July 30, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  Job Trends

  Life Sciences Industry Continues to See Job Creations as Pandemic Surges On

  As the world continues to navigate through the coronavirus pandemic, many biopharma companies are surging ahead with job creations. Check out these companies that have made recent job expansion announcements.

  July 30, 2020

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Drug Development

  AbbVie Eyes Regulatory Approval for Atogepant After Positive Phase III Migraine Study

  Atogepant, an oral CGRP receptor antagonist, is an experimental migraine treatment AbbVie gained through its acquisition of Allergan.

  July 30, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  Biopharma Update on the Novel Coronavirus: July 31

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 31, 2020.

  July 30, 2020

   · 

  4 min read

   · 

  BioSpace Editorial Staff
• 

  Pharm Country

  J&J’s COVID-19 Vaccine Generates Antibodies in Primates, Preclinical Data Shows

  This morning Johnson & Johnson announced preclinical data that showed its lead vaccine candidate protected against infection with SARS-CoV-2, the virus that causes COVID-19.

  July 30, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Career Advice

  3 Tips for Writing an ATS-Friendly Resume

  If you are looking for a new job, it is crucial to have an ATS friendly resume. Let’s discuss how to do this and why they’re so popular with hiring managers.

  July 30, 2020

   · 

  3 min read

   · 

  Laura Brothers